AnaptysBio (ANAB) PT Lowered to $70 at TD Cowen
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
TD Cowen lowers ANAB target to $70; current price $58.44.
Target: $70
Posted price: $58.44
Analyst firm: Scotiabank
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.